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Transcriptomic analysis of Spodoptera frugiperda Sf9 cells
resistant to Bacillus thuringiensis Cry1Ca toxin reveals that
extracellular Ca2+, Mg2+ and production of cAMP are involved
in toxicity
Claude Castella, David Pauron, Frédérique Hilliou, Van Tran Trang, Nathalie Zucchini-Pascal,
Armel Gallet and Pierre Barbero*
ABSTRACT
Bacillus thuringiensis (Bt) produces pore forming toxins that have
been used for pest control in agriculture for many years. However,
their molecular and cellular mode of action is still unclear. While a first
model – referred to as the pore forming model – is the most widely
accepted scenario, a secondmodel proposed that toxins could trigger
an Mg2+-dependent intracellular signalling pathway leading to cell
death. Although Cry1Ca has been shown to form ionic pores in the
plasmamembrane leading to cell swelling and death, we investigated
the existence of other cellular or molecular events involved in Cry1Ca
toxicity. The Sf9 insect cell line, derived from Spodoptera frugiperda,
is highly and specifically sensitive to Cry1Ca. Through a selection
program we developed various levels of laboratory-evolved Cry1Ca-
resistant Sf9 cell lines. Using a specific S. frugiperda microarray we
performed a comparative transcriptomic analysis between sensitive
and resistant cells and revealed genes differentially expressed in
resistant cells and related to cation-dependent signalling pathways.
Ion chelators protected sensitive cells from Cry1Ca toxicity
suggesting the necessity of both Ca2+ and/or Mg2+ for toxin action.
Selected cells were highly resistant to Cry1Ca while toxin binding
onto their plasma membrane was not affected. This suggested a
resistance mechanism different from the classical ‘loss of toxin
binding’. We observed a correlation between Cry1Ca cytotoxicity and
the increase of intracellular cAMP levels. Indeed, Sf9 sensitive cells
produced high levels of cAMP upon toxin stimulation, while Sf9
resistant cells were unable to increase their intracellular cAMP.
Together, these results provide new information about the
mechanism of Cry1Ca toxicity and clues to potential resistance
factors yet to discover.
KEY WORDS: Bacillus thuringiensis, Cry1Ca, Sf9 cells, Resistance,
Toxins, Transcriptomic
INTRODUCTION
Bacillus thuringiensis (Bt) is a Gram-positive bacterium that
produces proteins with a wide variety of insecticidal properties.
These microbial insecticides have been used for decades as pest
control agents and they represent an alternative to chemical
pesticides in a modern agriculture that strives to be more
respectful to the environment and to human health. Moreover,
observations of insect resistance to classical chemical pesticides
favoured the development and use of the insecticidal weapons
produced by Bt (Chattopadhyay and Banerjee, 2018).
The major insecticidal weapons of Bt are two multigenic families
of toxins, cry and cyt (Crickmore et al., 1998). Cry proteins are
produced as protoxins in crystal inclusions during Bt sporulation
phase. They belong to the pore forming toxins (PFT) class of
bacterial toxins (Palma et al., 2014). After spore and crystal
ingestion they are delivered to the insect intestinal tract where their
activation occurs allowing binding to midgut epithelial cells that
results in cell lysis and death of the target insect (Raymond et al.,
2010). Two different modes of action on intestinal cells have
been proposed and particularly well documented for Cry1A
toxins. The first and well-established model, referred to as the
pore-forming model, requires the sequential binding to two
specific receptors localized at the plasma membrane of insect
intestinal cells: a cadherin receptor protein (CADR) and a glycosyl-
phosphatidylinositol (GPI) membrane-anchored aminopeptidase N
(APN). This sequential binding allows pre-pore complex formation
and membrane insertion where they act as functional cationic-
specific pores causing osmolytic lysis of targeted cells (Jiménez-
Juárez et al., 2007; Soberón et al., 2000; Zhuang et al., 2002). The
second model of Cry action, completely independent of pore
formation, is referred to as the signal transduction model. Zhang and
colleagues showed that an Mg2+-dependent signalling pathway is
essential to Cry1A-induced cell death. This model also starts with
the binding of Cry1A to the primary receptor CADR triggering the
recruitment and activation of a heterotrimeric G protein, activation
of an adenylyl cyclase (AC), and elevation of intracellular cyclic
AMP (cAMPi). This second messenger then activates a protein
kinase A (PKA) whose activity is shown to be important for toxin-
induced cell death (Zhang et al., 2005, 2006). If CADR and APN
were the first proteins identified as Cry receptors in insects,
numerous other molecules that specifically bind Cry toxins, such as
alkaline phosphatase or ABC transporter have been reported
(Heckel, 2012; Pigott and Ellar, 2007). The existence of these
many potential receptors makes it more difficult to demonstrate a
single mode of action of Cry toxins.
Despite all the studies published on Cry1A toxins, numerous
events are still missing in the scenario of toxin action leading to
insect cell death (Vachon et al., 2012). Cry1C has been described as
a pore forming toxin able to oligomerize and form ionic channelsReceived 10 July 2018; Accepted 22 March 2019
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after membrane insertion (Laflamme et al., 2008; Peyronnet et al.,
2001). Previous studies using histological sections or purified
plasma membranes of insect epithelial midgut cells revealed
specific Cry1C receptors with low or no competition with Cry1A
toxins (Agrawal et al., 2002; Alcantara et al., 2004; Kwa et al.,
1998). Cry1C and Cry1A toxins specifically bind to distinct
isoforms of APN present in the brush border membrane ofManduca
sexta insect (Luo et al., 1996; Masson et al., 1995). Moreover, Liu
and colleagues have shown that resistance of the diamondback moth
to Cry1C was not the result of reduced binding of this toxin to insect
midgut membranes, i.e. a resistance mechanism different from that
observed for Cry1A-resistant insect (Liu et al., 2000). Finally,
Cry1C has been shown to be effective against Cry1A-resistant
insects or to act synergistically with Cry1A on target insects
(Abdullah et al., 2009; Xue et al., 2005). Pyramiding of the cry1A
and cry1C genes in transgenic plants has been shown to be an
effective strategy for delaying the evolution of insect (Tang et al.,
2017; Cao et al., 2002). However, field population of diamondback
moth repeatedly selected in laboratory for their resistance to Cry1C
presented various levels of cross-resistance with members of the
Cry1A toxin sub-class (Liu et al., 2001). Taken together, all these
data are revealing the complexity of Cry toxin action and are
suggesting that Cry1A and Cry1C toxins may have different
mechanisms of toxicity. Knowledge of the molecular events
involved in Cry1C mode of action would allow a better use of
this toxin as a potential alternative to Cry1A and the understanding
of resistance mechanisms developed by insects.
The fall armyworm, Spodoptera frugiperda (J. E. Smith), is one
of the most serious pests ravaging economically important crops
across the American continent and was recently spotted in Africa
(Goergen et al., 2016; Nagoshi and Meagher, 2008). Transgenic
crops expressing Bt toxins have been widely and efficiently used
against S. frugiperda. However, numerous cases of laboratory- or
field-evolved resistance to Cry toxin have been reported (Farias
et al., 2014; Storer et al., 2010). In order to mimic strategies
developed by S. frugiperda to reduce its susceptibility to toxins we
engineered a resistant cellular model using Sf9 cells. These cells are
derived from S. frugiperda and have been intensively used as an
insect model to study Cry1C toxicity. Among all the Lepidoptera
cell lines studied by Kwa and colleagues, Sf9 cells appeared highly
and specifically sensitive to Cry1C with more than 98% of the cells
affected (swollen cells) after 3 h of toxin treatment (Kwa et al.,
1998). However, a cell cycle-dependent resistance to Cry1C was
observed in Sf9 cells. Cells arrested in G2-M phase were insensitive
to Cry1C and gradually regained their sensitivity when the arresting
agent was removed (Avisar et al., 2005).
In the present study we selected two levels of resistance to
Cry1Ca in Sf9 cells. Genes differentially expressed between
resistant selected cell lines and the wild-type sensitive one were
studied. Our analysis led us to focus on the molecular mechanism
involving cation-dependent cellular pathway that could be involved
in Cry1Ca toxicity.
RESULTS
Development and characterization of Sf9 cells resistant to
Cry1Ca toxin
Sf9 cells are known to be susceptible to the Cry1C Bt toxin (Kwa
et al., 1998). We first verified if the Sf9 cell line we were using was
still highly and specifically sensitive to the Cry1Ca toxin. Viability
tests were performed onto Sf9 wild-type (Sf9wt) cells in the
presence of increasing concentrations of different Bt toxins
(Fig. 1A). Solubility problems prevented us from calculating
LD50 of Cry1Ab on Sf9 cells. Nevertheless, as observed in the inset
in Fig. 1 and as reported by others (Bretschneider et al., 2016)
Cry1Ab (white triangles) was not efficient in killing cells, while
Cry1Ca (black circles) efficiently killed the cells with a lethal dose,
giving 50% dead cells (LD50) evaluated at 0.9±0.15 mg/l. In order
to study the mode of action of Cry1Ca and to investigate resistance
mechanisms observed in S. frugiperda, we started a selection
Fig. 1. Sensitivity of Sf9wt cells to Cry toxins and development of
populations resistant to Cry1Ca. (A) Cells were incubated in complete
media containing various concentrations of Bt toxins. Cell viability was
evaluated by SYBR Gold staining. Inset shows the sensitivity of Sf9wt cells
to Cry1Ca toxin (●) as compared to Cry1Ab toxin (∇). Main graph shows cell
viability measurements of selected resistant Sf9 cell lines Sf9-LD50 (○) and
Sf9-LD80 (▾) compared to unselected Sf9wt (●) in the presence of Cry1C
toxin. Data are presented as the mean±s.d. of three independent
experiments performed in duplicate. Cry1Ca lethal concentration giving 50%
dead cells (LD50) is deduced from the curves. (B) Sensitive or resistant Sf9
cell lines were incubated for 18 h in toxin-free media (-Tox) or containing
0.9 mg/l of Cry1Ca toxin (+Tox) and observed using phase contrast
microscopy. Shown results are those from one experiment representative of
three independent experiments. Black arrows point to examples of affected
cells. Scale bar: 20 µm.
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program to develop cell strains resistant to this toxin. Doses
calculated for Sf9wt cells and corresponding to the LD50 and LD80
were used to select cells over 40 generations. At the end of the
selection program, resistant cell lines obtained using LD50 or LD80
doses were named Sf9-LD50 and Sf9-LD80 respectively. Cell viability
was tested at the 40th generation and LD50 measured for Sf9-LD50
(white circles in Fig. 1A) and Sf9-LD80 resistant cells (black triangles
in Fig. 1A) were 4.4±1.6 mg/l and 53±13 mg/l, respectively. We
calculated resistance factors (RF) using LD50Sf9-resistant/LD50Sf9wt
ratio: RF=4.9±0.8 for Sf9-LD50 cells and RF=58.9±2.8 for Sf9-LD80
cells. These resistant cells presented no significant time growth
difference as compared to Sf9wt cells used for the selection program
(data not shown). Cells were incubated for 18 h with 0.9 mg/l of
Cry1Ca and observed using phase contrast microscopy (Fig. 1B).
Both untreated Sf9 resistant cells presented no significant
morphological difference compared to Sf9 sensitive cells without
toxin in themedia.WhenCry1Cawas added in themedia, Sf9wt cells
showed morphological changes with vacuole formation and lysis.
While a large number of Sf9wt cells were killed, only a few Sf9-LD50
cells were affected and no change in Sf9-LD80 cell density and
morphology was observed.
Cry1Ca still binds to the plasma membrane of resistant
Sf9 cell lines
Among all known resistance mechanisms to Bacillus
entomopathogenic toxins, so far loss of plasma membrane receptor
binding appears to be one of the major mechanisms developed by
insects (Heckel et al., 2007). In order to verify if our resistant cell lines
established such a resistant mechanism, sensitive or resistant cells
were incubated for 40 min with complete media containing 3 mg/l of
Cry1Ca and immunostaining of the toxin was performed (Fig. 2).We
found no detectable difference in Cry1Ca membrane binding
between sensitive and resistant cells. When compared to the control
where no toxin was present in the media (left row), sensitive and
resistant cell lines showed comparable numbers of cells stained by
antibodies toCry1Ca.Most of the plasmamembraneswere uniformly
labelled with 2few punctuates eventually caused by toxin clustering
and/or oligomerization. The same experiment was performed with
Drosophila Schneider 2 (S2) cells known to be insensitive to Cry1Ca
toxin (bottom row). We found no Cry1Ca signal associated with the
plasma membrane of S2 cells supporting the idea that toxin
membrane binding is necessary for toxin action. Our data
suggested that the observed resistance in Sf9-LD50 and Sf9-LD80
cells is probably not caused by loss of a plasma membrane receptor.
Comparative transcriptomic analysis of Sf9 resistant versus
sensitive cell lines
Comparative transcriptomic analysis was performed onto total
mRNA isolated from sensitive Sf9 cells and resistant selected cells.
Expression levels were analysed on a specific S. frugiperda
microarray representing 9721 genes. To evaluate the potential
effects of cell aging and culture condition on gene expression, we
compared the expression patterns of the 8th (Sf9p8) and 40th
(Sf9p40) generations of wild-type cells. Only three showed genes-
coding for a Rho GTPase, a fatty acid-binding protein 2 (FABP2)
and an unidentified protein among the 9721 tested genes that were
significantly differently transcribed (Table S1, sheet 1). The
variations observed for the Rho GTPase and the FABP2 are in
accordance with previous studies showing that mRNA and protein
levels of these two molecules are regulated throughout the cell cycle
and cell aging, and are involved in the regulation of key components
of the cell cycle (Coleman et al., 2004; Pu et al., 1999; Yoon et al.,
2007). The low gene expression variation observed between Sf9p8
and Sf9p40 validated our global approach to identify genes with
expression profiles specifically modified during the establishment
of Cry1Ca resistance in Sf9 cells. Classification of the differentially
expressed genes using Gene Ontology terms revealed numerous
biological processes modified in both resistant selected cells:
transcription, translation, transport, binding, enzymatic activity,
secretion, signalling and structural (Fig. 3A). Among all these
biological processes, we observed that as RF increases, an
enrichment of terms related to the cell signalling pathway (from
4% in Sf9-LD50 to 8% in Sf9-LD80) and to transcription processes
(from 6% in Sf9-LD50 to 14% in Sf9-LD80) are seen. Moreover, as
shown in the Venn diagram proposed in Fig. 3B, while 82 and 125
genes presented variation of expression specifically in Sf9-LD50
and in Sf9-LD80 cells respectively, only 49 genes appeared to be
common to both selected cell lines. Thirty-six out of these 49
common genes differentially up- or downregulated in the same way
in both resistant cell lines and were identified (Table 1). While
numerous cellular processes were modified, we thought that these
common genes could play a central role in the mechanism of
resistance to Cry1Ca or in its mode of action. Among these 36
identified common genes, 17% appeared to be possibly involved in
cellular pathways requiring or modifying cation intracellular
Fig. 2. Cry1Ca binding to the plasma membrane of Sf9 and S2 cell
lines, Sf9wt cells or resistant cell lines Sf9-LD50 or Sf9-LD80 were
incubated 40 min in complete media free of toxin (−Cry1C) or
containing 3 mg/l of Cry1Ca toxin (+Cry1C). Immunostaining was
performed using primary antibodies to Cry1Ca and secondary antibodies
coupled to Alexa Fluor 488. Toxin localization was visualized using an
inverted epifluorescence microscope. As a control, immunostaining was
carried out onto cells incubated without toxin (−Cry1C) and S2 cells
(S2+Cry1C) insensitive to Cry1Ca toxin. The numbers indicate the
percentage of cells immunostained. Shown results are those from one
experiment representative of two independent experiments. Scale bar:
20 µm.
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concentrations. Moreover, Omic analysis revealed that cation
homeostasis and/or cation-dependent cell signalling processes
were modified in cells or insects resistant to Bt toxins (Candas
et al., 2003; Canton et al., 2015; Nanoth Vellichirammal et al.,
2015). All these observations led us to investigate the importance of
cations in Cry1Ca toxicity using Sf9-LD80 only; the selected cell
lines with the highest calculated RF.
Protective effect of divalent ions chelators
Divalent ions have been described as common key players in the
main proposed modes of action of Bt toxins (Zhang et al., 2006). To
investigate their contribution to Cry1Ca toxicity, we carried out Sf9
cells intoxication during 18 h with different concentrations of toxin
in the presence of 5 mM EDTA or 5 mM EGTA and we evaluated
cell viability. EDTA chelates Mg2+ and Ca2+, whereas EGTA
preferentially chelates Ca2+. No detectable mortality was observed
when Sf9wt or Sf9-LD80 cells were incubated with chelators only
(data not shown). As shown in Fig. 4A, both EDTA and EGTA
displayed a protective effect regarding toxin action when compared
to Sf9 cells intoxicated without ion chelators in the media. The
LD50s measured for Sf9wt (black circles), Sf9wt with EDTA (black
triangles) and Sf9wt with EGTA (white circles) were 2.1±0.4,
35.8±6 and 18±5 mg/l of Cry1Ca, respectively. Calculation of
LD50s ratios revealed an 8.57±0.76-fold decrease in Cry1Ca
toxicity when EGTA was present in the media and a 17.05±0.43-
fold decrease for EDTA. Observation under a light microscope
revealed a slight effect on the morphology of Sf9wt protected cells
(Fig. 4B) and Sf9-LD80 resistant cells (data not shown). Most of the
Sf9wt cells protected by chelator presence (+Tox +EDTA or +Tox
+EGTA) were still intact compared to cells with Cry1Ca only
(+Tox), but they appeared less flattened and round shaped than
untreated Sf9 (−Tox). These minor morphological changes were not
observed when both cell lines were incubated with media containing
chelators only (data not shown) suggesting that these changes were
not the result of cell adhesion alteration caused by extracellular ions
clustering. In order to verify whether the observed protective effect
of both EDTA and EGTA was not the result of Cry1Ca binding
loss onto Sf9 plasma membrane, we performed immunostaining
using Cry1Ca primary antibodies in presence of 5 mM chelators
(Fig. 5). Control cells (CT) were incubated with EDTA only. The
percentage of membrane stained cells was calculated in the different
conditions. While 0% of total cells were membrane-labelled in the
control, we did not observe significant difference in toxin binding
onto Sf9wt membranes in presence or absence of EDTA or
EGTA. Once again, Sf9-LD80 cells presented comparable results to
Sf9wt cells with about one-third of total cells positive for toxin
binding. All these results revealed a significant protective effect of
cationic chelators suggesting an important contribution of both
Mg2+ and Ca2+ in Cry1Ca action. This protective effect was not
likely due to loss of interaction of Cry1Ca with plasma membrane
binding regions.
Cry1Ca toxin induces Cyclic AMP production
Previous studies proposed that Cry protein toxicity involves
activation of an Mg2+-dependent signalling pathway leading to
the production of the second messenger cAMP (Zhang et al., 2006).
Since (i) divalent ions chelators appeared to have a protective effect
upon Cry1Ca toxicity and (ii) numerous crosstalk have been
described between cAMP pathway and calcium signal (Hofer,
2012), we incubated Sf9 cells with the toxin in media with or
without chelators and we evaluated cAMP production (Fig. 6).
Activation with forskolin, a direct adenylate cyclase (AC) activator,
was used as a positive control for cAMP production. As expected,
Sf9wt cells treated with 100 µM forskolin presented a 35-fold
increase of cAMP level when compared to untreated cells. A
significantly stronger effect was observed in Sf9wt cells treated with
Cry1Ca, with a 96-fold increase. When stimulations were achieved
in presence of EDTA in the media, we observed a specific inhibitory
Fig. 3. Transcriptomic analysis of resistant Sf9
cell lines. (A) Pie charts of the biological functions
of detected genes over or under-expressed in Sf9
resistant cell lines. Sf9-LD50 and Sf9-LD80 are
compared to Sf9wt sensitive cells. Genes identified
on the Spodo Database are classified into seven
categories using Gene Ontology terms: transport,
binding, enzymatic activity, secretion, signalling,
structural, transcription and translation. (B) Venn
diagram showing number of genes differentially
expressed in Sf9-LD50 only (82), in Sf9-LD80 only
(125) and common in both resistant cell lines (49).
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effect on cAMP production affecting forskolin treatment while
cAMP production triggered by Cry1Ca was only slightly affected.
Indeed, the fold increase in cAMP using forskolin or Cry1Ca were
respectively reduced to 18-fold and 92-fold. Finally, when EGTA
was present in the media of stimulated cells we observed a specific
inhibitory effect onto cAMP production due to Cry1Ca toxin with a
cAMP fold increase significantly reduced from 96-fold to 35-fold.
We observed no EGTA inhibitory effect on cAMP levels obtained
after forskolin treatment. Taken together these results showed that
Cry1Ca was able to trigger the production of cAMP in Sf9 cells
through a mechanism requiring extracellular Ca2+.
Sf9-LD80 cells are impaired in cAMP production
Since Cry1Ca action seemed to require increase of intracellular
concentration of cAMP ([cAMP]i) we wondered whether the
resistant cell line Sf9-LD80 was able to produce this second
messenger. Sf9wt sensitive cells or Sf9-LD80 resistant cells were
stimulated with forskolin or Cry1Ca and the increase in cAMP was
measured (Fig. 7). In contrast to what we observed for Sf9wt cells,
Sf9-LD80 had an altered response to stimulation by both forskolin
and the toxin. While 100 µM forskolin increased the cAMP amount
eightfold (less than one quarter of what we observed for Sf9wt
cells), no cAMP increase was detected after stimulation with
Cry1Ca. This experiment suggests that Sf9-LD80 cells could
overcome Cry1Ca toxicity by blocking cAMP-dependent
signalling normally triggered by the toxin in sensitive cells.
DISCUSSION
In this report, we describe Sf9 cells resistant to the Cry1Ca toxin
obtained after a selection program. We tested Sf9wt cells for their
sensitivity to another Cry toxin (Cry1Ab) at toxin concentrations up
to 100 mg/l in the same time conditions as with Cry1Ca and
confirmed that theywere almost ineffective on these cells, suggesting
a peculiar mode of action for Cry1Ca. The LD50measuredwith these
cells that are specifically sensitive to Cry1Ca were in the same
concentration range to what was observed in previous studies (Kwa
et al., 1998). Therefore, we started our selection program using LD50
or LD80 Cry1Ca doses and we obtained cell lines with an increasing
resistance factor, named Sf9-LD50 and Sf9-LD80.
While the so-called ‘mode 1 resistance’, the most frequently
mechanism of Cry toxins resistance, results in toxin receptor
binding defects (Gahan et al., 2001; Jurat-Fuentes et al., 2011;
Morin et al., 2003) we observed no detectable difference in Cry1Ca
binding to the plasma membrane of Sf9 sensitive or resistant cells
(Fig. 2). It is important to note that this approach using immuno-
fluorescence microscopy could not rule out an undetectable small
diminution of receptor affinity or loss of a secondary receptor,
which could be sufficient to perturb toxin toxicity onto Sf9-LD80
Table 1. List of genes with the same expression profile in both resistant cell lines
Accession No. Description Expression Oligo ID
KJ622099.1 Agrobiotis segetum enoyl-CoA hydratase + adhoc-25862
NP_001124379 Bombix mori diuretic hormone 31 + adhoc-40459
NP_001091832 Bombyx mori eukaryotic initiation factor 4E-1 + adhoc-27125
XM_021336943 Helicoverpa armigera organic cation transporteur protein-like + adhoc-27137
NG_053148.1 Homo sapiens calmodulin binding transcription activator 1 + adhoc-38874
XM_004922449.3 Predicted: Bombyx mori zinc finger protein 608 + adhoc-34656
XM_002763546.4 Predicted: Callithrix jacchus UDP glucuronosyltransferase family 2 + adhoc-38447
XM_021328952.1 Predicted: Helicoverpa armigera eukaryotic translation initiation factor 3 + adhoc-40626
XM_021340684.1 Predicted: Helicoverpa armigera receptor expression-enhancing protein 5 + adhoc-38756
XM_021342409.1 Predicted: Helicoverpa armigera RNA-binding protein pno1 + adhoc-35838
XM_021329746.1 Predicted: Helicoverpa armigera silencing protein 10 + adhoc-40628
XM_021325195.1 Predicted: Helicoverpa armigera uncharacterized LOC110369688 + adhoc-33957
XM_021335084.1 Predicted: Helicoverpa armigera uncharacterized LOC110376574 + adhoc-44429
XM_014576615.1 Predicted: Pelodiscus sinensis cartilage intermediate layer protein + adhoc-34293
XM_011570118.1 Predicted: Plutella xylostella coatamer subunit delta + adhoc-34845
XM_011560908.1 Predicted: Plutella xylostella protein BCCIP homolog + adhoc-40531
XM_011159698.1 Predicted: Solonopsis invicta venom serine carboxypeptidase + adhoc-40864
XP_967064 Predicted: Tribolium castaneum ran-binding protein homolog + adhoc-36521
KC188795.1 Spodoptera exigua 14-3-3 protein epsilon + adhoc-36480
EU259815.1 Spodoptera exigua activated C kinase 1 receptor (RACK1) + adhoc-36385
JN164650.1 Spodoptera frugiperda cap’n’collar isoform C + adhoc-39822
DQ295917.1 Spodoptera frugiperda G protein-coupled receptor + adhoc-40926
FO681374.1 Spodoptera frugiperda sequence from BAC clone 96D18 + adhoc-41072
JQ979047.1 Spodoptora littoralis cytochrome P450 CYP305B1 + adhoc-39913
XM_013328524.1 Predicted Amyelois transitella epidermal retinol dehydrogenase 2- like − adhoc-38974
XM_013330116.1 Predicted Amyelois transitella translation initiation factor 3 subunit M − adhoc-34731
XM_021334894.1 Predicted: Helicoverpa armigera calcineurin B homologous protein 1 − adhoc-34328
XM_021342567.1 Predicted: Helicoverpa armigera eukaryotic translation initiation factor 5A − adhoc-39550
XM_021326538.1 Predicted: Helicoverpa armigera retinoblastoma-like protein 1 − adhoc-27605
XM_021325970.1 Predicted: Helicoverpa armigera transcription factor E2F7-like − adhoc-38939
XM_021338618.1 Predicted: Helicoverpa armigera ubiquinone monooxygenase COQ6 − adhoc-38013
XM_021337093.1 Predicted: Helicoverpa armigera uncharacterized protein − adhoc-44377
XM_021333277.1 Predicted: Helicoverpa armigera importin subunit alpha-7 − adhoc-27546
KT218668.1 Spodoptera frugiperda ribosomal protein L23A − adhoc-34322
AY072287.1 Spodoptera frugiperda ribosomal protein L3 − adhoc-41009
AY646107.1 Trichoplusia ni putative cytoplasmic actin variant 2 − adhoc-44378
36 identified genes out of 49 genes common to Sf9-LD50 and Sf9-LD80 cells and regulated the same way in both resistant selected cell lines are listed. Bold lines
highlight genes potentially involved in cellular pathways requiring or modifying cation intracellular concentrations. Upregulated, +; downregulated, −. Oligo IDs
correspond to the identity of the oligonucleotide sequence spotted onto the S. frugiperda microarray.
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cells. However, our binding results are strongly correlated with our
transcriptomic analysis. Indeed, we did not detect any significant
variation of expression of previously described and widely accepted
plasmamembrane toxin receptor as CADRor APN. All these results
strongly suggest that Cry1Ca resistance observed in the Sf9-LD50 or
Sf9-LD80 cells is probably not caused by loss or alteration of plasma
membrane binding.
Use of differential transcriptomic analysis to understand
resistance mechanisms developed by insects to counteract toxicity
is a challenging task. It generates a large amount of data and shows
that cellular responses are likely diverse and affect many cellular
processes as observed in Fig. 3A and in other studies (Nanoth
Vellichirammal et al., 2015; Canton et al., 2015). Therefore, we
decided to focus on genes differentially expressed in the same way
in both selected resistant cells, as they may be key players in
resistance processes (Table 1). Hence, we highlighted genes
involved in cation-dependent signalling pathways or cation
homeostasis. For example, calmodulin-binding transcription
activator (CAMTA) is activated after a rise in intracellular calcium
concentration ([Ca2+]i). Both Ca2+ and calmodulin (Cam) bind to
CAMTA, which translocates into the nucleus and activates its target
genes (Finkler et al., 2007). Like CAMTA, the predicted
Calcineurin B homologue was differentially expressed in both
selected resistant cell lines. Calcineurin is a calcium-activated
protein phosphatase that participates in diverse biological functions
through interaction with various partners (Li et al., 2011). It is
composed of two subunits, a catalytic subunit (CnA) and a
regulatory subunit (CnB) containing Ca2+ binding sites. Increased
intracellular Ca2+ allows binding of the cations to the regulatory
sites, which initiates a series of conformational changes and the
activation of calcineurin (Yang and Klee, 2000). Thus, in both
examples a rise in [Ca2+]i appears as a crucial event in the activation
of our potential key players in Cry1Ca resistance.
Earlier studies showed the involvement of divalent cations in Cry
activity. Cry1Ca toxicity increases with the presence of calcium in a
Fig. 4. Sf9wt cells are protected from Cry1Ca toxicity by ion chelators.
(A) Sf9wt cells were incubated for 18 h in complete media containing various
concentrations of Cry1Ca toxin alone, Cry1Ca toxin +5 mM EGTA or Cry1Ca
toxin +5 mM EDTA. Cell viability was evaluated by SYBR Gold staining.
Data are presented as the mean±s.d. of three independent experiments
done in duplicate. (B) Sf9wt cells were observed using phase contrast
microscopy 18 h after incubation with 5 mg/l of Cry1Ca toxin (+Tox),
Cry1Ca toxin +5 mM EDTA (+Tox +EDTA) or Cry1Ca toxin +5 mM EGTA
(+Tox +EGTA). Cell morphology was compared to Sf9wt cells in complete
media only (−Tox). Shown results are those from one experiment
representative of three independent experiments. Scale bar: 20 µm.
Fig. 5. Cry1Ca plasma membrane binding is not affected by the
presence of chelators. Sf9wt cells (left row) or Sf9-LD80 cells (right row)
were incubated for 40 min in complete media containing 3 mg/l of Cry1Ca
toxin alone (+Tox), Cry1Ca toxin +5 mM EDTA (+Tox +EDTA) or Cry1Ca
toxin +5 mM EGTA (+Tox +EGTA). Immunostaining was performed
using primary antibodies to Cry1Ca and secondary antibodies coupled
to Alexa Fluor 488. Toxin localization was visualized using an inverted
epifluorescence microscope. As a control (CT), immunostaining was carried
out onto cells incubated without toxin. The numbers indicate the percentage
of cells immunostained. Shown results are those from one experiment
representative of two independent experiments. Scale bar: 20 µm.
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dose-dependent manner and the toxin induces a rapid elevation of
intracellular calcium in treated cells (Monette et al., 1997). We
followed intoxication of Sf9 sensitive cells in the presence of EDTA
or EGTA and observed a protective effect for both ion chelators
(Fig. 4). Similar to the observations for Cry1Ab binding onto S5
cells (Zhang et al., 2005), neither EDTA nor EGTA affected the
interaction of Cry1Ca with the plasma membrane of Sf9wt or Sf9-
LD80 cell lines (Fig. 5). The protection obtained with the Ca
2+
chelator EGTAwas not the result of a loss of toxin binding capacity
to Sf9wt cells and could be the result of the failure of the cells to
increase their [Ca2+]i in response to the toxin. If pore formation or
the signal transduction pathway are the two main models of toxin
action leading to cell death, a third model was proposed in which
formation of toxin oligomers followed by pore formation due to
oligomer insertion in cell membrane could participate in
establishment of a signalling pathway (Jurat-Fuentes and Adang,
2006). Pores composed of Cry1Ca toxin do not induce only
potassium-selective channels but increase the permeability of the
plasma membrane of Sf9 cells to numerous solutes (Guihard et al.,
2000; Villalon et al., 1998). The toxin has been shown to trigger an
intracellular calcium surge in Sf9 cells and is still toxic when Sf9
cells are incubated in media containing barium, a divalent cation
used as potassium channel blocker (Monette et al., 1997; Schwartz
et al., 1991). So, the protective effect of calcium chelators could
result from blocking Ca2+ entry in the cell through poorly selective
channels obtained by toxin membrane insertion and the incapacity
of this calcium surge to contribute to a Ca2+-dependent signal
pathway, leading to cell death. When we used the Mg2+ chelator
EDTA, we observed a stronger decrease of Cry1Ca toxicity
compared to protection obtained with EGTA (Fig. 4). Like Zhang
and colleagues, who observed that Cry1Ab still binds to the plasma
membrane of High five cells in the presence of EDTA (Zhang et al.,
2005), we saw no binding loss of Cry1Ca to Sf9wt sensitive or
Sf9-LD80 resistant cells when incubated with 5 mM EDTA (Fig. 5).
So, as described for Cry1Ab, depletion of Mg2+ using EDTA could
prevent Cry1Ca-induced cellular response and stop the
establishment of a Mg2+-dependent intracellular pathway critical
to promote cell death (Zhang et al., 2006). Since Mg2+ is essential
for adenylyl cyclase (AC) to catalyse the formation of cAMP
(Tesmer et al., 1999; Pieroni et al., 1995) and since AC activity has
been shown by Zhang et al. (2005) to participate in Cry1Ab toxicity,
we monitored cAMP production after Sf9 cell intoxication with
Cry1Ca (Fig. 6). Treatment of Sf9 sensitive cells with forskolin,
used as positive control, produced a 38-fold increase of intracellular
[cAMP] while Cry1Ca presented an even stronger stimulation of
cAMP production. [cAMP]i increase after toxin treatment was not
affected by the presence of EDTA, whereas the cAMP increase was
reduced two fold in Sf9wt cells stimulated with forskolin plus
EDTA as compared to forskolin alone. In contrast, EGTA affected
only Cry1Ca-induced cAMP production. These results suggest the
importance of Ca2+ ions in toxin action via formation of cAMP.
Since numerous AC activities have be shown to be regulated by
[Ca2+]i (Willoughby and Cooper, 2007), Cry1Ca, after formation of
pores in the Sf9 membrane, could activate AC through entry in cells
of extracellular Ca2+. Näsman’s work showed that applying 1 mM
EGTA to Sf9 cell media blocked the raise in [Ca2+]i and drastically
reduced the increase of cAMP levels after stimulation with
octopamine (Näsman et al., 2002). Thus, the increase in cAMP
levels observed in our cells treated with Cry1Ca could be due to the
activation of calcium-dependent AC, with EGTA protecting cells by
preventing the increase in calcium and AC activation.
If EGTA was the most efficient to reduce cAMP elevation in
response to Cry1Ca stimulation, EDTA which preferentially binds
Mg2+ appeared themost protective againstCry1Ca toxicity. This effect
of EDTA could be explained, on one hand, by the necessity of Mg2+
for catalytic activity of ACs. Indeed, Mg2+ which binds to the active
Fig. 6. cAMP is produced in Sf9wt cells after toxin treatment. Sf9wt cells
were incubated 20 min in complete media only (−) or media supplemented
with (+) 100 µM forskolin (Fors.), 1 mg/l Cry1Ca toxin (Tox.), 5 mM EDTA or
5 mM EGTA. After incubation, cytosolic HCl extract were performed and
cAMP amount measured using an immunoassay kit. cAMP fold increase
was evaluated compared to non-stimulated cells (see Materials and
Methods). Data are presented as the mean±s.e. of three independent
experiments done in duplicate. Student’s t-tests were used for comparisons
among groups. ***P<0.001; n.s., not significant compared to the condition
with forskolin only. “P<0.05, “““P<0.001, compared to the condition with
toxin only.
Fig. 7. Sf9-DL80 cells are affected in cAMP production. Sf9wt or
Sf9-LD80 cells were incubated for 20 min in complete media only (CT) or
media supplemented with 100 µM forskolin (+Fors.) or 1 mg/l Cry1Ca toxin
(+Tox.). After incubation, cytosolic HCl extracts were performed and cAMP
amount measured using an immunoassay kit. cAMP fold increase was
evaluated compared to non-stimulated cells (see Materials and Methods).
Data are presented as the mean±s.e. of three independent experiments
done in duplicate. Student’s t-tests were used for comparisons among
groups. *P<0.05, compared to Sf9wt cells stimulated with forskolin only.
“P<0.05, compared to Sf9-LD80 stimulated with toxin only.
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domain of ACs is essential for their activity and therefore for the
synthesis of cAMP (Pieroni et al., 1995; Tesmer et al., 1999). On the
other hand, Mg2+ could have a more central role than Ca2+ in
participating in the activation of numerous proposed other partner
proteins involved in toxin-induced signalling pathway, beginningwith
heterotrimeric G protein activation (Sprang, 1997). However, while in
the absence of Mg2+ we observed an effect on cAMP production by
forskolin stimulation, EDTA did not seem to prevent the increase of
cAMP after the action of the toxin. Cry1Ca might be triggering the
production of cAMPby activation of anMg2+-independent ACwhose
regulation requires Ca2+ (Braun et al., 1977; Litvin et al., 2003).
It has been proposed that the mechanism of action of the toxin can
be independent of cAMP production (Knowles and Farndale, 1988;
Portugal et al., 2017). Portugal and colleagues clearly demonstrated
that both Cry1Ab and Cry1Ac toxins triggered cell death in CF1
cells via pore formation activity. While they saw neither the
activation of PKA nor an increase in intracellular cAMP
concentration during Cry1Ab or Cry1Ac intoxication, in our
hands Cry1Ca triggered an increase of the [cAMP]i in favour of a
peculiar mode of action of this toxin (Fig. 6). Moreover, we
observed (Fig. 7) that the Sf9-LD80 resistant cell line was unable to
elevate [cAMP]i in response to Cry1Ca treatment. Thus, the
[cAMP]i increase seems to be an essential element to the toxicity
induced by Cry1Ca but appeared insufficient since forskolin,
although it may increase cAMP levels, presents no toxicity onto Sf9
cells. While Zhang and colleagues observed a similar lack of
forskolin toxicity, Cry1Ab cytotoxic effects were potentialised
when sensitive cells were pre-treated with forskolin (Zhang et al.,
2006). In light of these observations, they proposed that if cAMP is
a key player in toxin effect through activation of PKA, specific
PKA-dependent effector(s) mediating downstream cell death
activity might be stimulated by Cry1Ab but not by forskolin. All
these observations raise the question of how specificity is
maintained in this cAMP/PKA system, activated by both forskolin
and toxins (Cry1Ab and Cry1Ca) but where only Bt toxins are
capable of generating cellular events leading to cell death. Since we
identified Ca2+ as another important molecule involved in the
Cry1Ca mode of action, we might think that through toxin pore
formation, Ca2+ entry in the cell would stimulates Ca2+-dependent
events interacting with the PKA pathway. The protein kinase C
(PKC) pathway could be such Ca2+-dependent event which,
together with the PKA activation, would allow the toxin to
perform its cytotoxic effect. PKC is a large superfamily of protein
kinases comprising numerous members activated by elevation of
intracellular Ca2+ concentration (Webb et al., 2000). Coordinated
activity and cross-talk between the PKA and PKC pathways have
been shown in multiple cellular processes (Robinson-White and
Stratakis, 2002). It might be possible that such a scenario was
encountered in our intoxicated cells where forskolin was not
sufficient, and Ca2+ was necessary, to promote cell death using
Cry1Ca. It is worth noting that since the intracellular responses to
Cry1 toxins studied using cell lines in culture remain controversial,
this scenario will have to be validated in larvae of target insects.
Finally, we observed in both selected resistant cell lines the
upregulation of a gene described as the homologous of S. exigua
activated C kinase receptor (RACK1). This PKC-activated binding
protein (Mochly-Rosen, 1995) has been shown as a specific binding
partner of a cAMP-phosphodiesterase (PDE) and was proposed as a
potential point of cross-talk between the cAMP and PKC signalling
pathways (Bird et al., 2010; Yarwood et al., 1999). RACK1 and its
partners could, after intoxication by Cry1Ca, be the node of
convergence of the two signalling pathways mentioned above.
In summary, Sf9-LD80 cells, which were the most resistant to
Cry1Ca toxicity, were affected in cAMP production. Furthermore,
our results have shown the importance of Ca2+ and Mg2+ ions in the
toxicity of Cry1Ca. These ions may participate in different ways to
the establishment of a cAMP-dependent signalling pathway
following the binding of the toxin to the membrane of Sf9 cells.
Both the signalling model and the pore forming model may
contribute to Cry1Ca toxicity as was observed in the third model of
toxin action proposed by Jurat-Fuentes and colleagues for Cry1A
toxin, or more recently for the pore-forming α-Toxin from
Clostridium septicum (Chakravorty et al., 2015; Jurat-Fuentes and
Adang 2006). At low concentrations, Cry1Ca insertion in the
plasma membrane could create pores, allowing Ca2+ entry in the cell
and resulting in the activation of a cAMP-dependent cell death
pathway. Future studies focusing on the identification and
characterization of proteins involved in cAMP turnover, such as
PDEs and their regulators, may identify new resistance factors, and
contribute to a better understanding of the molecular mode of action
of Cry1Ca and insect resistance mechanisms.
MATERIALS AND METHODS
Insect cell lines culture and selection
Sf9 cell lines (ATCC® Number: CRL-1711™; Invitrogen) from ovarian
tissue of pupal stage lepidopteran S. frugiperdawere routinely maintained in
complete medium (Grace’s Insect Medium, Cambrex) containing 10%
foetal bovine serum (FBS), penicillin (50 Ul/ml) and streptomycin
(50 μg/ml), at 28°C, and spread when 80% confluence was reached. For
resistant strain selection, cells were plated onto six-well plates until they
reached 80% confluence and treated for 24 h at 28°C, either with Cry1Ca
toxin at the lethal dose giving 50% dead cells (LD50), or at the lethal dose
giving 80% dead cells (LD80). These lethal doses were calculated for Sf9wt
when treated with various concentrations of Cry1Ca toxin (see below).
Treated cells were further rinsed with Dulbecco’s phosphate buffer saline
(D-PBS) and allowed to recover for 2 days. After this recovery time, cells
were harvested and spread in a new six-well plate for another round of
selection. Forty rounds were done using the LD50 or LD80 toxin doses.
Recovered resistant cells after the selection program were referred to as
Sf9-LD50 and Sf9-LD80. Potential effects of aging were evaluated on cells
grown for 40 rounds without toxin (Sf9p40) as compared to eight rounds
(Sf9p8). S2 cells (R690-07, Invitrogen) derived from primary culture of late
stage Drosophila melanogaster embryos were cultured at 24°C on Schneider
medium (Invitrogen).
Cry1 toxin production and purification
Cry1Ab or Cry1Ca toxins were independently produced from Bt strain 407-
(minus)pHT320 transformed with plasmid expressing the full sequence of
the cry1Ca gene (Sanchis et al., 1999) or expressing the full sequence of the
cry1Ab gene (gift from M. Gohar, Micalis Institute, INRA, France). Cells
were grown for 65 h at 30°C in HCT media containing 0.3% glucose and
10 mg/l erythromycin, spun down by centrifugation at 6500 g for 15 min at
4°C and were passed through a Potter homogenizer. After five cycles of
centrifugation/homogenisation, Cry inclusion bodies were loaded onto a
discontinuous sucrose gradient (weight/volume: 79/72/67%) which was
then centrifuged at 23,000 rpm for 19 h at 4°C in a SW27 rotor (Beckman).
Cry inclusion bodies were collected at the interface, washed with distilled
water and solubilized 1 h at 37°C in 50 mMNa2CO3/NaHCO3, 10 mMDTT
pH 10.2. Cry concentration was determined using the Bradford method
(Protein Assay Reagent, BioRad) and toxin activation was further
performed via a 16 h incubation at 37°C under gentle agitation in 2%
trypsin (weight/weight). Activated Cry were purified by size-exclusion
chromatography on Äkta-FPLC (GE Healthcare).
Viability test
1.5×105 cells were plated per well onto a 96-well microassay plate (BD
Falcon) and left for 24 h at 28°C. Then cells were incubated for 18 h in
complete media containing increasing concentration of activated Cry1Ab or
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Cry1Ca toxins (from 10−1 to 10−5 g/l). Before addition of the toxins, cells
were pre-incubated 30 min in fresh media or, when divalent ions effects
were measured, in fresh media containing 5 mM divalent ion chelating
agents; ethylene-diamine-tetra-acetic-acid (EDTA) or ethylene-glycol-
bis(2-aminoethylether)-N,N,N,N′-tetra-acetic-acid (EGTA) (Sigma-
Aldrich). After toxin incubation, cells were rapidly incubated with SYBR
GoldTM dye (Molecular Probes) at a 1:10,000 dilution and observed using
an inverted epifluorescence equipped microscope (Eclipse TE2000-U,
Nikon) coupled to a CCD camera (Orca ER, Hamamatsu). Two pictures per
toxin concentration were used to count both stained and unstained cells
(300–400 total cells). Cell viability was calculated by the formula: (stained
cells/total cells)×100. Data were then treated on the SigmaPlot 10.0 software
(Systat Software) and typical dose-response sigmoid curves were obtained
with non-linear estimation. Cry1Ca lethal doses giving 50% (LD50) or 80%
(LD80) dead cells were directly deduced from the curves. Resistance ratio
(RR) due to treatments were obtained by the formula: LD50 (Sf9+treatment)/
LD50 (Sf9 in free media).
Microarray experimental design
Oligonucleotides were designed from 79148 ESTs sequences recovered
from eight S. frugiperda tissues. The assembly analysis programme CAP3
identified 10092 contigs and singleton from these ESTs. The S. frugiperda
microarray consisted of 9773 60-mer oligonucleotides (synthesized by
Sigma-Aldrich) designed to match unique contigs or singletons and to suit
hybridization conditions (average GC content: 46%; average Tm: 46°C).
The experimental design of each comparison (Sf9-LD50 versus Sf9p40,
Sf9-LD80 versus Sf9p40, Sf9p8 versus Sf9p40) was made using Cy3- and
Cy5-labelled cDNA. Each comparison consisted of six microarrays, three
biological replicates hybridized with dye swap (fully balanced dye swap
design) and duplicate spots. The microarray were hybridized with cDNA
prepared as described earlier (Le Goff et al., 2006) and scanned using
GenePixPro scanner (Axon,version 3.01). Experimental data and associated
microarray designs have been deposited in the NCBI Gene Expression
Omnibus (accession number: GSE20507, http://www.ncbi.nlm.nih.gov/geo/)
using Mediante database for data transfer (Le Brigand and Barbry, 2007).
Microarray data analysis
Data analysis was performed using the Bioconductor suite of statistical
packages and limmaGUI (Gentleman et al., 2004; Wettenhall and Smyth,
2004). Specific expression intensity was obtained by subtracting the
background intensity from the foreground intensity for each non-flag spot
(all flagged spots were eliminated). The expression data were normalised by
within-array normalization with the ‘loess method’ and between-array
normalization using the ‘quantile method’ (Yang et al., 2003). The linear
model for the series of arrays and empirical Bayes method was then applied
for assessing differential expression (Smyth, 2004). The false discovery rate
of the P-value for multiple tests was controlled using the Benjamini-
Hochberg method. Differentially expressed genes were selected if the
absolute value of log2-fold-change was greater than 1 and adjusted P-value
below 0.01 and if the average intensity was greater than twice the average
background. In order to provide an overall measure of evidence of
differential expression, we used the Fisher’s method for combining adjusted
P-values from independent tests of significance of duplicate spots (Hess and
Iyer, 2007). Lists of genes differentially up- or downregulated specifically in
Sf9-LD50, specifically in Sf9-LD80 or common to both cell lines are
available in the Supplementary information (Table S1).
Immunocytochemistry and live imaging
Cells were incubated for 40 min with complete media containing 3 mg/l of
activated Cry1Ca toxin. Then cells were washed with D-PBS and fixed for
20 min in 4% paraformaldehyde/PBS solution at room temperature. After
two rinses in D-PBS cells were quickly rinsed in 100% methanol and
incubated in PBS containing 100 mM glycine. Cells were further incubated
2 h at room temperature with gentle agitation in PBS 10% normal goat
serum. Immunostainings were performed with primary antibodies to
Cry1Ca (rat serum obtained from an immunization program, Eurogentec,
Belgium) at the 1:2000 dilution and secondary antibodies goat anti-rat IgG,
Alexa Fluor 488 conjugated (Molecular Probes). Immunostaining without
primary antibodies was performed as control. Cells were then rinsed with
PBS and mounted under Mowiol® 4-88 based media (Polysciences).
Images were obtained using an inverted epifluorescence equipped
microscope (Eclipse TE2000-U, Nikon) coupled to a CCD camera (Orca
ER, Hamamatsu). Four images per experiment were used to count both
stained and unstained cells (150–200 total cells) and the percentage of
stained cells was calculated by the formula: (stained cells/total cells)×100.
Cell morphology of living Sf9 cells was examined directly in culture wells
under light microscopy after 18 h incubation in complete media containing
5 mg/l of Cry1Ca with or without 5 mM of chelator agents.
cAMP measurement
Cells were plated onto a 24-well microassay plate (BD Falcon) until
reaching 80% confluency, washed with D-PBS and incubated for 20 min at
28°C with complete media only (control, CT) or containing Cry1Ca toxin
(1 mg/l) or forskolin (100 µM). Cells were further incubated 10 min in HCl
0.1 M at 4°C, scrapped, vigorously shaken and centrifuged at 600×g for
10 min at 4°C. Supernatants were collected and proteins were quantified by
the Bradford method assay. Amounts of cAMP/mg of protein were
measured in HCl extracts using the Direct cAMP enzyme immunoassay kit
according to the manufacturer instruction (Sigma-Aldrich). The cAMP fold
increases were calculated by the ratio of cAMP amount in stimulated
conditions divided by the cAMP amount in non stimulated cells (−).
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Portugal, L., Munoz-Garay, C., Martıńez de Castro, D. L., Soberón, M. and
Bravo, A. (2017). Toxicity of Cry1A toxins from Bacillus thuringiensis to CF1 cells
does not involve activation of adenylate cyclase/PKA signaling pathway. Insect
Biochem. Mol. Biol. 80, 21-31. doi:10.1016/j.ibmb.2016.11.004
Pu, L., Igbavboa, U., Wood, W. G., Roths, J. B., Kier, A. B., Spener, F. and
Schroeder, F. (1999). Expression of fatty acid binding proteins is altered in aged
mouse brain. Mol. Cell. Biochem. 198, 69-78. doi:10.1023/A:1006946027619
Raymond, B., Johnston, P. R., Nielsen-LeRoux, C., Lereclus, D. andCrickmore,
N. (2010). Bacillus thuringiensis: an impotent pathogen? Trends Microbiol. 18,
189-194. doi:10.1016/j.tim.2010.02.006
Robinson-White, A. and Stratakis, C. A. (2002). Protein kinase a signaling.
Ann. N. Y. Acad. Sci. 968, 256-270. doi:10.1111/j.1749-6632.2002.tb04340.x
Sanchis, V., Gohar, M., Chaufaux, J., Arantes, O., Meier, A., Agaisse, H., Cayley,
J. and Lereclus, D. (1999). Development and field performance of a broad-
spectrum nonviable asporogenic recombinant strain of Bacillus thuringiensis with
greater potency and UV resistance. Appl. Environ. Microbiol. 65, 4032-4039.
Schwartz, J. L., Garneau, L., Masson, L. and Brousseau, R. (1991). Early
response of cultured lepidopteran cells to exposure to δ-endotoxin from Bacillus
10
RESEARCH ARTICLE Biology Open (2019) 8, bio037085. doi:10.1242/bio.037085
B
io
lo
g
y
O
p
en
 by guest on August 1, 2019http://bio.biologists.org/Downloaded from 
thuringiensis: Involvement of calcium and anionic channels. Biochim. Biophys.
Acta 1065, 250-260. doi:10.1016/0005-2736(91)90237-3
Smyth, G. K. (2004). Linear models and empirical bayes methods for assessing
differential expression in microarray experiments. Stat. Appl. Genet. Mol. Biol. 3,
Article3. doi:10.2202/1544-6115.1027
Soberón, M., Perez, R. V., Nunez-Valdez, M. E., Lorence, A., Gomez, I., Sanchez,
J. and Bravo, A. (2000). Evidence for intermolecular interaction as a necessary
step for pore-formation activity and toxicity of Bacillus thuringiensis Cry1Ab toxin.
FEMS Microbiol. Lett. 191, 221-225. doi:10.1016/S0378-1097(00)00394-3
Sprang, S. R. (1997). G proteins, effectors and GAPs: structure and mechanism.
Curr. Opin. Struct. Biol. 7, 849-856. doi:10.1016/S0959-440X(97)80157-1
Storer, N. P., Babcock, J. M., Schlenz, M., Meade, T., Thompson, G. D., Bing,
J. W. and Huckaba, R. M. (2010). Discovery and characterization of field
resistance to Bt Maize: Spodoptera frugiperda (Lepidoptera: Noctuidae) in puerto
rico. J. Econ. Entomol. 103, 1031-1038. doi:10.1603/EC10040
Tang, H., Chen, G., Chen, F., Han, L. and Peng, Y. (2017). Development and
relative fitness of Cry1C resistance in Chilo suppressalis. Pest Manag. Sci. 74,
590-597. doi:10.1002/ps.4740
Tesmer, J. J., Sunahara, R. K., Johnson, R. A., Gosselin, G., Gilman, A. G. and
Sprang, S. R. (1999). Two-metal-ion catalysis in adenylyl cyclase. Science 285,
756-760. doi:10.1126/science.285.5428.756
Vachon, V., Laprade, R., Schwartz, J. L., Fortea, E., Lemieux, V., Potvin, L.,
Chikwana, V., Griffin, S., Hey, T., McCaskill, D. et al. (2012). Current models of
the mode of action of Bacillus thuringiensis insecticidal crystal proteins: a critical
review. J. Invertebr. Pathol. 111, 1-12. doi:10.1016/j.jip.2012.05.001
Villalon, M., Vachon, V., Brousseau, R., Schwartz, J. L. and Laprade, R. (1998).
Video imaging analysis of the plasma membrane permeabilizing effects of
Bacillus thuringiensis insecticidal toxins in Sf9 cells. Biochim. Biophys. Acta 1368,
27-34. doi:10.1016/S0005-2736(97)00184-3
Webb, B. L., Hirst, S. J. and Giembycz, M. A. (2000). Protein kinase C
isoenzymes: a review of their structure, regulation and role in regulating airways
smooth muscle tone and mitogenesis. Br. J. Pharmacol. 130, 1433-1452. doi:10.
1038/sj.bjp.0703452
Wettenhall, J. M. and Smyth, G. K. (2004). limmaGUI: a graphical user interface for
linear modeling of microarray data. Bioinformatics 20, 3705-3706. doi:10.1093/
bioinformatics/bth449
Willoughby, D. and Cooper, D. M. (2007). Organization and Ca 2+ regulation of
adenylyl cyclases in cAMP microdomains. Physiol. Rev. 87, 965-1010. doi:10.
1152/physrev.00049.2006
Xue, J.-L., Cai, Q.-X., Zheng, D.-S. and Yuan, Z.-M. (2005). The synergistic activity
between Cry1Aa and Cry1c from Bacillus thuringiensis against Spodoptera
exigua and Helicoverpa armigera. Lett. Appl. Microbiol. 40, 460-465. doi:10.1111/
j.1472-765X.2005.01712.x
Yang, S.-A. and Klee, C. B. (2000). Lowaffinity Ca 2+ -binding sites of calcineurin B
mediate conformational changes in calcineurin A. Biochemistry 39, 16147-16154.
doi:10.1021/bi001321q
Yang, C.-Y., Pang, J.-C., Kao, S.-S. and Tsen, H.-Y. (2003). Enterotoxigenicity and
cytotoxicity of bacillus thuringiensis strains and development of a process for
Cry1Ac production. J. Agric. Food Chem. 51, 100-105. doi:10.1021/jf025863l
Yarwood, S. J., Steele, M. R., Scotland, G., Houslay, M. D. and Bolger, G. B.
(1999). The RACK1 signaling scaffold protein selectively interacts with the cAMP-
specific phosphodiesterase PDE4D5 isoform. J. Biol. Chem. 274, 14909-14917.
doi:10.1074/jbc.274.21.14909
Yoon, Y. S., Choo, J. H., Yoo, T., Kang, K. and Chung, J. H. (2007). RhoB is
epigenetically regulated in an age- and tissue-specific manner. Biochem.
Biophys. Res. Commun. 362, 164-169. doi:10.1016/j.bbrc.2007.08.002
Zhang, X., Candas, M., Griko, N. B., Rose-Young, L. and Bulla, L. A. (2005).
Cytotoxicity of Bacillus thuringiensis Cry1Ab toxin depends on specific binding of
the toxin to the cadherin receptor BT-R1 expressed in insect cells. Cell Death
Differ. 12, 1407-1416.
Zhang, X., Candas, M., Griko, N. B., Taussig, R. and Bulla, L. A. Jr. (2006). A
mechanism of cell death involving an adenylyl cyclase/PKA signaling pathway is
induced by the Cry1Ab toxin of Bacillus thuringiensis. Proc. Natl. Acad. Sci. USA
103, 9897-9902. doi:10.1073/pnas.0604017103
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